CRA1000
a non-peptidic corticotropin-releasing hormone receptor type 1 antagonist
Also Known As:
2-(N-(2-methylthio-4-isopropylphenyl)-N-ethylamino)-4-(4-(3-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl)-6-methylpyrimidine; CRA-1000; 2-Pyrimidinamine, N-ethyl-4-(4-(3-fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl)-6-methyl-N-(4-(1-methylethyl)-2-(methylthio)phenyl)-
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Arai, Keiko:
3 articles
(10/2004 - 12/2002)
|
2. | Shibasaki, Tamotsu:
3 articles
(10/2004 - 12/2002)
|
3. | Ohata, Hisayuki:
2 articles
(10/2004 - 12/2002)
|
4. | Kawana, S:
1 article
(07/2010)
|
5. | Liang, Z:
1 article
(07/2010)
|
6. | Shimoda, T:
1 article
(07/2010)
|
7. | Suzuki, H:
1 article
(07/2010)
|
8. | Mano-Otagiri, Asuka:
1 article
(10/2004)
|
9. | Sekino, Azusa:
1 article
(10/2004)
|
10. | Kaneko, Katsumi:
1 article
(02/2003)
|
Related Diseases
Related Drugs and Biologics